Sulfonamides As Selective Na(V)1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (Am-0466) That Affords Robust in Vivo Activity Russell F. Graceffa , Alessandro A. Boezio , Jessica Able , Steven Altmann , Loren M. Berry , Christiane Boezio , John R. Butler , Margaret Chu-Moyer , Melanie Cooke , Erin F. DiMauro , Thomas A. Dineen , Elma Feric Bojic , Robert S. Foti , Robert T. Fremeau , Angel Guzman-Perez , Hua Gao , Hakan Gunaydin , Hongbing Huang , Liyue Huang , Christopher Ilch , Michael Jarosh , Thomas Kornecook , Charles R. Kreiman , Daniel S. La , Joseph Ligutti , Benjamin C. Milgram , Min-Hwa Jasmine Lin , Isaac E. Marx , Hanh N. Nguyen , Emily A. Peterson , Gwen Rescourio , John Roberts , Laurie Schenkel , Roman Shimanovich , Brian A. Sparling , John Stellwagen , Kristin Taborn , Karina R. Vaida , Jean Wang , John Yeoman , Violeta Yu , Dawn Zhu , Bryan D. Moyer , Matthew M. Weiss JOURNAL OF MEDICINAL CHEMISTRY（2017）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
